PROVIDER PROFILE · NPI 1790736155

Gustavo RiveroM.D.

PRACTICEMGMC LLCSee all providers at this practice →

Hematology-OncologyWashington, DCI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

148

Unique beneficiaries

—

Total services

511

Distinct HCPCS

Medicare payment

$44K

Peer benchmark

Total Medicare services vs. 48 Hematology-Oncology providers in DC — below median (cohort median 735).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$61

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Levofloxacin12 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$507

Payment records

By payment type

Food and Beverage$462

Education$45

REFERRAL NETWORK

Where Gustavo Rivero's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	87	545
CHI ST. LUKE'S HEALTH BAYLOR COLLEGE OF MEDICINE MEDICAL CENTER	39	228
Yochai Birnbaum Cardiology · Houston, TX	20	72
Mark Udden Hematology-Oncology · Houston, TX	14	52
Martha Mims Hematology-Oncology · Houston, TX	13	38
John Duncan Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TX	12	26
James Wilson Cardiology · Houston, TX	11	15
SHANNON, RHONDA	11	27

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history